Federal Reserve Faces Diminishing Case for Rate Cuts as April Jobs Data Shows Stabilizing Labor Market Microsoft Flags 190B Capital Spending Need by 2026 Amid Memory Price Surge DOE Highlights Batteries Charging and EVs Policy Focus May Shape Industry Trajectory New Fed Chair Kevin Warsh Faces Potential Headwinds Amid Trumps Policy Legacy Paul Tudor Jones Says Kevin Warsh No Chance of Cutting Fed Rates Market Implications Robinhood Opens Platform to AI Agents Expanding Automated Trading Access SGRP Q4 2024 Earnings EPS Misses Estimates Amidst Undisclosed Revenue LWLG Q3 2024 Earnings Continued RD Investment as Revenue Yet to Materialize Weatherford International Q1 2026 Earnings Strong EPS Beat Highlights Operational Discipline CARL Q1 2026 Earnings Personal Surgery Specialist Beats EPS Estimates Stock Rises WRLD Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Rallies Ready Capital Corporation RC Q1 2026 Earnings Massive EPS Miss Signals Severe Challenges Wen Acquisition Corp WENN Holds Steady at 1027 as Market Awaits Catalyst LivePerson LPSN Gains 45 as Stock Tests Key Resistance Level Biohaven Ltd BHVN Shares Slide 67Pressing Key Support at 1000 iSpecimen Inc ISPC Slips 2 as Stock Tests Support Near 321 Smart Sand Inc SND Holds Steady Near Support as Energy Sector Shows Mixed Signals Nifty Holds Marginal Gains as Markets Await Key Triggers Bond Yields Geopolitical Risks and FII Flows in Focus OLP Q1 2026 Earnings NetLease REIT Beats EPS Estimates on Stable Portfolio Performance Stellar V Capital Corp Warrant SVCCW Holds Steady at 020 as Support and Resistance Tighten SPX Technologies SPXC Declines 171 Support and Resistance Levels in Focus Crown Castle CCI Slips Slightly Approaching Key Support at 864 Pediatrix Medical Group MD Holds Steady Near Resistance Consolidation Phase Ahead PROCEPT BioRobotics PRCT Rises on Positive Momentum Testing Key Resistance at 2847 Hologic Inc Holds Steady at 7601 as Traders Assess Support and Resistance Levels Origin Bancorp OBK Holds Near Support Amid Modest Decline Cardiol Therapeutics Inc CRDL Modestly Advances as It Holds Above Key Support